MDNT Manufacturing via Advanced Flow Reactor Technology

Mr. Omar Abbassi | U.S. Army Armament Research, Development and Engineering Center

WP-201623

Objective

The U.S. Army has an interest in developing Insensitive Munitions (IM) to replace high explosives (HE) formulations without sacrificing lethality and performance. MDNT (1-methyl-3,5-dinitro-1,2,4-triazole) bridges a technical gap between Comp B and IMX-104 for a meltable IM HE solution that does not compromise performance or output. The current manufacturing for MDNT utilizes batch chemistry which, in this case, suffers from scalability, low product yields, low throughput, and generates a large volume of waste. A need exists to move away from batch chemistry towards a more environmental and economic method. Advanced Flow Reactor (AFR) technology is an example of continuous flow chemistry, which allows for seamless scalability, increased product yields, decreased waste generation, and increased safety. In addition, the increased heat transfer capabilities offered by the AFR system afford new opportunities to evaluate an alternative chemistry that is impossible to attempt in a batch reactor; continuous chemistry thus becomes an enabling technology. The overall objective of this project is to demonstrate a continuous process for the manufacturing of MDNT utilizing AFR technology in a full-scale production G3 reactor system, as opposed to a batch process.

Back to Top

Technology Description

Nalas and ARDEC have identified AFR as a safety-conscious, environmentally friendly, and cost-effective technology for the high throughput production of MDNT. The AFR production method will be demonstrated with success being measured by reduction of solvent waste generated, ease of product isolation, increased yield, and increased operator safety. Employing AFR technology for the manufacture of MDNT supports the following sub-objectives:

  • Reduction of solvent waste per pound of MDNT from DAMT by 75% as the dilution will be decreased from 66 volumes to ~15 volumes.
  • Increase in in situ reaction mixture yield of MDNT from 50% to 75%.
  • Reduction of operator exposure to process conditions/steps by 95%. A G3 reactor at 65 mL/plate has approximately 650 mL of volume (10 plate system) at any given point in the reaction.

Back to Top

Benefits

This project benefits the Department of Defense by providing a high throughput scalable process for the replacement of Comp B to mitigate the environmental impacts of RDX and TNT. PEO Ammo views MDNT as a direct Comp B replacement in certain end items for which IMX-104 lacks the required performance output such as the M67 fragmentation grenade and the M1061 enhanced fragmentation mortar. Cost savings associated with an AFR-based MDNT production, versus batch process, will help its transition. (Anticipated Project Completion - 2019)

Back to Top

Points of Contact

Principal Investigator

Mr. Omar Abbassi

US Army ARDEC

Phone: 973-724-3660

Fax: 973-724-5869

Share